Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
After Bite Classic 3.5% liquid
190400000BBBRUI
|
Proprietary compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Agalsidase alfa 1mg/1ml solution for infusion vials
0908010AAAAABAB
|
Agalsidase alfa | Agalsidase alfa | Nutrition and Blood | No data available |
|
Agalsidase alfa 3.5mg/3.5ml solution for infusion vials
0908010AAAAAAAA
|
Agalsidase alfa | Agalsidase alfa | Nutrition and Blood | No data available |
|
Agalsidase beta 35mg powder for solution for infusion vials
0908010AEAAABAB
|
Agalsidase beta | Agalsidase beta | Nutrition and Blood | No data available |
|
Agalsidase beta 5mg powder for solution for infusion vials
0908010AEAAAAAA
|
Agalsidase beta | Agalsidase beta | Nutrition and Blood | No data available |
|
Agenerase 150mg capsules
0503010I0BBAAAA
|
Agenerase | Amprenavir | Infections | No data available |
|
Agenerase 15mg/ml oral solution
0503010I0BBACAC
|
Agenerase | Amprenavir | Infections | No data available |
|
Agenerase 50mg capsules
0503010I0BBABAB
|
Agenerase | Amprenavir | Infections | No data available |
|
Agitane 2mg tablets
0409020C0BEAAAD
|
Agitane | Trihexyphenidyl hydrochloride | Central Nervous System | No data available |
|
Agitane 5mg tablets
0409020C0BEABAE
|
Agitane | Trihexyphenidyl hydrochloride | Central Nervous System | No data available |
|
Agrimony herb tincture
190606000BCTVA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Agrippal vacc inj 0.5ml pre-filled syringes
1404000H0BHAAAF
|
Agrippal | Influenza | Immunological Products and Vaccines | No data available |
|
Aidpore microporous tape 2.5cm
20100000745
|
Aidpore microporous tape 2.5cm | Surgical Adhesive Tape | Dressings | No data available |
|
Ailax Forte oral suspension
0106020B0BDABAB
|
Ailax | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Ailax oral suspension
0106020B0BDAAAA
|
Ailax | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Aimovig 140mg/1ml solution for injection pre-filled pens
0407042T0BBABAB
|
Aimovig | Erenumab | Central Nervous System | No data available |
|
Aimpart XL 2mg tablets
0409010H0BHAAAK
|
Aimpart XL | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Aimpart XL 4mg tablets
0409010H0BHABAL
|
Aimpart XL | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Aimpart XL 8mg tablets
0409010H0BHACAM
|
Aimpart XL | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Aindeem 1mg tablet
1309000W0BCAAAA
|
Aindeem | Finasteride | Skin | No data available |
|
Aircast pneumatic walker diabetic system extra large
21290000158
|
Aircast pneumatic walker diabetic system extra large | Pressure Offloading Device | Appliances | No data available |
|
Aircast XP diabetic walker system large
21290000157
|
Aircast XP diabetic walker system large | Pressure Offloading Device | Appliances | No data available |
|
Aircast XP diabetic walker system medium
21290000156
|
Aircast XP diabetic walker system medium | Pressure Offloading Device | Appliances | No data available |
|
Aircast XP diabetic walker system small
21290000155
|
Aircast XP diabetic walker system small | Pressure Offloading Device | Appliances | No data available |
|
Aircort 100micrograms/dose nasal spray
1202010I0BDAAAC
|
Aircort | Budesonide | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.